U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
(Check One):
[ ] Form 10-K and Form 10-KSB
[ ] Form 20-F
[ ] form 11-K
[X] Form 10-Q and Form 10-QSB
[ ] Form N-SAR
For Period Ended: March 31, 1997
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Period Ended:
If the notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification relates:
Part I - Registrant Information
Full Name of Registrant: Medizone International, Inc.
Former Name if Applicable: (originally, Madison Funding, Inc.)
Address of Principal Executive
Office (Street and Number)
City, State and Zip Code: 123 East 54th Street
New York, New York 10022
Part II - Rules 12b-25(b) and (c)
If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b) the following should
be completed. (Check box if appropriate).
[ X ] (a) The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense;
[ X ] (b) The subject annual report, semi-annual report, transition report on
Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion thereof will be filed on or
before the fifteenth calendar day following the prescribed due date; or the
subject quarterly report or transition report on Form 10-Q, or portion thereof
will be filed on or before the fifth calendar day following the prescribed due
date; and
<PAGE>
[ ] (c) The accountant's statement or other exhibit required by Rule 12b-25(c)
has been attached if applicable.
Part III - Narrative
The Registrant could not substantiate certain financial information so as to
complete its financial statements for the first quarter.
Part IV - Other Information
(1) Name and telephone number of person to contact in regard to this
notification:
Andrew E. Goldstein, Esq. (212) 826-2000
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under section 13 or 15(d) of
the Securities Exchange Act of 1934 or section 30 of the Investment Company Act
of 1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such report(s) been filed? If the answer is no,
identify report(s).
The registrant has not filed its annual report on Form 10-K for the period
ended December 31, 1996.
|_| Yes |X| No
(3) Is it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion thereof?
|_| Yes |X| No
If so; attach an explanation of the anticipated change, both narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable estimate
of the results cannot be made.
Medizone International, Inc.
(Name of Registrant as specific in charter)
has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Date May 15, 1997 By s/Arthur P. Bergeron
------------------------ -------------------------
Arthur P. Bergeron, Vice President
and Chief Financial Officer
